Suggestions
Parag Jhaveri
Gen AI for Healthcare | Deep Tech VC | Board member | Haas MBA
Professional Background
Parag Jhaveri is a dynamic and high-energy healthcare executive recognized for his extensive experience in building businesses and developing innovative products aimed at improving human health. With a robust history in early-stage investments and mergers and acquisitions (M&A) within deep tech life sciences and healthcare startups, he has established himself as a leading figure in the healthcare investment landscape. Parag possesses an in-depth understanding of the healthcare ecosystem, having worked with a diverse range of clients across various sectors, including private equity, nonprofit health systems, biotech, specialty pharmaceuticals, and digital health startups.
Through over a decade of executive leadership experience, Parag has demonstrated unyielding dedication to empowering teams, solving complex problems, and executing strategic initiatives that foster growth and innovation. He has built a track record of successful outcomes through well-informed decision-making, effectiveness in generating solid returns on investment, and strategic foresight in evaluating and facilitating new market opportunities. His hands-on experience includes collaboration with both early-stage and late-stage venture capital firms, further refining his aptitude as an investor in transformative healthcare solutions.
Education and Achievements
Parag's educational background reflects his commitment to excellence in both technical and business domains. He holds a Master of Business Administration (MBA) in Finance & Strategy from the prestigious Haas School of Business at the University of California, Berkeley. Additionally, he earned a Master’s degree in Industrial Engineering from Louisiana Tech University and a Bachelor of Engineering (B.E.) in Mechanical Engineering from the University of Mumbai. This educational foundation has equipped him with the analytical and strategic skill sets necessary to navigate the complexities of the healthcare sector.
In terms of achievements, Parag has been pivotal in several significant acquisitions across the healthcare landscape, notably with companies like Ortho Clinical Diagnostics acquired by Carlyle, Celgene acquired by Bristol Myers Squibb, and intraFusion acquired by McKesson. He has also played an instrumental role in multiple active healthcare ventures, directly contributing to companies such as Codetta Bio, Scribe Bio, and CellSonics, to name a few.
Distinctive Expertise
Parag's vast expertise encompasses a broad range of competencies essential for success in the healthcare and life sciences sectors. His areas of distinctive expertise include:
-
Business Development and Strategy: Parag has led comprehensive business development initiatives and established strategic partnerships resulting in significant competitive advantages and market positioning for various organizations.
-
Growth and Competitive Assessment: He excels in evaluating growth opportunities while crafting and implementing effective market strategies tailored to the evolving landscape of healthcare.
-
Operational Excellence in M&A: With end-to-end M&A experience, Parag has managed commercial due diligence (CDD), operational due diligence (ODD), and post-merger integration processes for transactions ranging from $20 million to over $78 billion in enterprise value.
-
Financial Acumen: Parag is well-versed in financial statement analysis and valuation modeling, continuously leveraging these skills to assess investment opportunities critically.
-
Regulatory Experience: He possesses extensive knowledge of FDA regulations and has successfully launched multiple applications, including instruments and software, meeting stringent compliance standards.
-
Data Analytics: An advocate for leveraging data for improved insights, Parag employs advanced data analytics techniques to derive meaningful conclusions that drive operational improvements.
Networks and Relations
As a citizen of the United States with a global network, Parag has established relationships with industry leaders and investors across the United States, India, and Singapore. His extensive connections include early-stage venture capital firms, late-stage growth capital providers, and private equity firms, enhancing his ability to foster collaborations that lead to innovation in healthcare.
Recent Projects and Collaborations
Parag has collaborated with a variety of visionary companies focused on groundbreaking solutions within the healthcare sector. His contributions to firms like Robinhood, which made waves with a successful IPO, illustrate his keen ability to identify potential in emerging technology-related companies. He has also actively engaged in transformative ventures such as Menlo Micro and Phenom, solidifying his position as a leading venture capitalist with an eye for innovative healthcare technologies.
Parag Jhaveri’s unique blend of technical knowledge, business acumen, and leadership expertise has positioned him as a thought leader committed to leveraging innovation to advance public health and enhance well-being. His journey thus far demonstrates unwavering passion and resilience as he continues to build extraordinary companies that are set to reshape the future of healthcare.
Contact Information
For networking or inquiries, you can reach Parag Jhaveri at [email protected] or connect with him on LinkedIn.

